Wickman Sanna, Saukkonen Tero, Dunkel Leo
Hospital for Children and Adolescents, University of Helsinki, PL281, FIN-00029 HUS, Helsinki, Finland.
Eur J Endocrinol. 2002 Mar;146(3):339-46. doi: 10.1530/eje.0.1460339.
Our purpose was to study the sex steroid-mediated changes in serum insulin and lipid concentrations in boys during puberty.
We treated boys with constitutional delay of puberty either with testosterone plus placebo or with testosterone plus an aromatase inhibitor, letrozole, which inhibits the conversion of androgens to oestrogens. We demonstrated previously that during treatment with testosterone plus letrozole the increase in testosterone concentration was more than 5-fold higher than during treatment with testosterone plus placebo. The concentrations of 17beta-oestradiol, IGF-I and IGF-binding protein-3 increased during testosterone-plus-placebo treatment, but during testosterone-plus-letrozole treatment the concentrations remained unchanged. These divergent changes in the two groups enabled us to study the effects of sex steroids and GH on insulin sensitivity and lipid concentrations.
The insulin concentration in the testosterone-plus-placebo-treated group did not change. In contrast, in the testosterone-plus-letrozole-treated group, the concentration decreased during letrozole treatment, indicating improved insulin sensitivity. Changes in insulin and IGF-I concentrations within 12 and 18 months were correlated. In the testosterone-plus-placebo-treated group, the high-density lipoprotein cholesterol concentration did not change but in the testosterone-plus-letrozole-treated group the concentration decreased. The concentrations of low-density lipoprotein cholesterol (LDL-cholesterol) and triglycerides did not change in either of the groups.
The findings indicate that androgens do not directly alter insulin sensitivity in boys during puberty. In contrast, the observations suggest tight regulation of glucose--insulin homeostasis by GH in boys at this stage. Furthermore, our findings indicate that sex steroids do not significantly participate in the regulation of serum concentrations of LDL-cholesterol or triglycerides in boys during early and mid-puberty.
我们的目的是研究青春期男孩中由性类固醇介导的血清胰岛素和脂质浓度的变化。
我们对体质性青春期延迟的男孩进行治疗,一组给予睾酮加安慰剂,另一组给予睾酮加芳香化酶抑制剂来曲唑,来曲唑可抑制雄激素向雌激素的转化。我们之前证明,在睾酮加来曲唑治疗期间,睾酮浓度的升高比睾酮加安慰剂治疗期间高5倍以上。在睾酮加安慰剂治疗期间,17β-雌二醇、IGF-I和IGF结合蛋白-3的浓度升高,但在睾酮加来曲唑治疗期间,这些浓度保持不变。两组的这些不同变化使我们能够研究性类固醇和生长激素对胰岛素敏感性和脂质浓度的影响。
睾酮加安慰剂治疗组的胰岛素浓度没有变化。相比之下,在睾酮加来曲唑治疗组中,来曲唑治疗期间浓度降低,表明胰岛素敏感性提高。12个月和18个月内胰岛素和IGF-I浓度的变化具有相关性。在睾酮加安慰剂治疗组中,高密度脂蛋白胆固醇浓度没有变化,但在睾酮加来曲唑治疗组中,该浓度降低。两组中低密度脂蛋白胆固醇(LDL-胆固醇)和甘油三酯的浓度均未变化。
研究结果表明,雄激素在青春期男孩中不会直接改变胰岛素敏感性。相比之下,这些观察结果表明,在这个阶段,生长激素对男孩的葡萄糖-胰岛素稳态有严格的调节作用。此外,我们的研究结果表明,在青春期早期和中期,性类固醇在男孩血清LDL-胆固醇或甘油三酯浓度的调节中没有显著作用。